Partner Headlines - INFI

  1. Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind ...

    Benzinga
  2. Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ ...

    Benzinga
  3. A Portfolio To Support Cancer Treatments In Time For Prostate ...

    Benzinga
  4. Benzinga's Top Initiations

    Benzinga
  5. It's A Big Weekend For Biotech

    Benzinga
  6. JPM Securities Picks Through Biotech News For Winners

    Benzinga
  7. UPDATE: Infinity Pharmaceuticals Posts Q4 Loss

    Benzinga
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  9. Morning Market Losers

    Benzinga
  10. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday ...

    Benzinga
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. Infinity Announces Clinical And Preclincal Data For Duvelisib ...

    Benzinga
  13. Infinity Reports Topline Data From Phase 2a Exploratory Study ...

    Benzinga
  14. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  15. Pharmacyclics Price Target Cut On Higher Spending

    IBD
  16. Benzinga's Top Upgrades

    Benzinga
  17. JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

    Benzinga
  18. Infinity, AbbVie team on drug

    IBD
  19. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga
  20. Midday Gainers From Wednesday, September 3

    Benzinga
  21. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD
  22. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With ...

    Benzinga
  23. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga
  24. Benzinga's Volume Movers

    Benzinga
  25. Morning Market Movers

    Benzinga
  26. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. What You Need to Know About the Roche-InterMune Deal

    Benzinga
  29. Markets Open Higher; Burger King In Talks To Buy Tim Hortons

    Benzinga
  30. InterMune's Roche Deal Sends Peer Group Up

    Benzinga
  31. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  32. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals ...

    Benzinga
  33. The Top Five Drug Launches Of 2013

    IBD
  34. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on ...

    Benzinga
  35. Benzinga's Top Downgrades

    Benzinga
  36. Celgene's stock hits new high

    IBD
  37. Mid-Day Market Update: Sysco Shares Rise Following Merger with ...

    Benzinga
  38. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  39. Benzinga's Volume Movers

    Benzinga
  40. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  41. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  42. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  43. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals ...

    Benzinga
  44. Benzinga's Top Initiations

    Benzinga
  45. The Best Small Cap Performers of 2012

    Benzinga
  46. Stocks Hitting 52-Week Highs

    Benzinga
  47. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  48. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  49. Infinity Announces Closing of Public Offering and Exercise of ...

    Benzinga
  50. Stocks Hitting 52-Week Highs

    Benzinga
  51. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  52. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond ...

    Benzinga
  53. Infinity Pharma Shares Rebound Over $22 Following Phase I Data ...

    Benzinga
  54. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold ...

    Benzinga
  55. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  56. Stocks Hitting 52-Week Highs

    Benzinga
  57. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at ...

    Benzinga
  58. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  59. Health Care Sector Wrap

    FoxBusiness
  60. Synacor, American Capital Mortgage Investment Crp, Other Stocks ...

    FoxBusiness
  61. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  62. Morning Market Losers

    Benzinga
  63. Benzinga's Top Pre-Market Losers

    Benzinga
  64. A Peek Into The Market Before The Trading Starts

    Benzinga
  65. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to ...

    Benzinga
  66. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  67. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  68. Infinity Reports Update from Phase 2 Study of Saridegib Plus ...

    Benzinga
  69. Infinity Reports New Data from Phase 1b Trial of Saridegib in ...

    Benzinga
Trading Center